- NRx Pharmaceuticals (NASDAQ: $NRXP) CEO Dr. Jon
Post# of 186
(Total Views: 154)
Posted On: 08/04/2025 7:40:43 AM
- NRx Pharmaceuticals (NASDAQ: $NRXP)
CEO Dr. Jonathan Javitt offers an update on the company's late-stage pharmaceutical developments for bipolar depression, PTSD, and other CNS disorders, while continuing to advance FDA engagement for its proprietary pipeline.
https://finance.yahoo.com/news/street-show-68...00890.html
CEO Dr. Jonathan Javitt offers an update on the company's late-stage pharmaceutical developments for bipolar depression, PTSD, and other CNS disorders, while continuing to advance FDA engagement for its proprietary pipeline.
https://finance.yahoo.com/news/street-show-68...00890.html
(0)
(0)